Burden of arrhythmia in hospitalized HIV patients.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 22 08 2020
revised: 19 10 2020
accepted: 29 10 2020
pubmed: 10 12 2020
medline: 18 8 2021
entrez: 9 12 2020
Statut: ppublish

Résumé

The improved life expectancy observed in patients living with human immunodeficiency virus (HIV) infection has made age-related cardiovascular complications, including arrhythmias, a growing health concern. We describe the temporal trends in frequency of various arrhythmias and assess impact of arrhythmias on hospitalized HIV patients using the Nationwide Inpatient Sample (NIS). Data on HIV-related hospitalizations from 2005 to 2014 were obtained from the NIS database using International Classification of Diseases, 9th Revision (ICD-9) codes. Data was further subclassified into hospitalizations with associated arrhythmias and those without. Baseline demographics and comorbidities were determined. Outcomes including in-hospital mortality, cost of care, and length of stay were extracted. SAS 9.4 (SAS Institute Inc., Cary, NC) was utilized for analysis. A multivariable analysis was performed to identify predictors of arrhythmias among hospitalized HIV patients. Among 2 370 751 HIV-related hospitalizations identified, the overall frequency of any arrhythmia was 3.01%. Atrial fibrillation (AF) was the most frequent arrhythmia (2110 per 100 000). The overall frequency of arrhythmias increased over time by 108%, primarily due to a 132% increase in AF. Arrhythmias are more frequent among older males, lowest income quartile, and nonelective admissions. Patients with arrhythmias had a higher in-hospital mortality rate (9.6%). In-hospital mortality among patients with arrhythmias decreased over time by 43.8%. The cost of care and length of stay associated with arrhythmia-related hospitalizations were mostly unchanged. Arrhythmias are associated with significant morbidity and mortality in hospitalized HIV patients. AF is the most frequent arrhythmia in hospitalized HIV patients.

Sections du résumé

BACKGROUND BACKGROUND
The improved life expectancy observed in patients living with human immunodeficiency virus (HIV) infection has made age-related cardiovascular complications, including arrhythmias, a growing health concern.
HYPOTHESIS OBJECTIVE
We describe the temporal trends in frequency of various arrhythmias and assess impact of arrhythmias on hospitalized HIV patients using the Nationwide Inpatient Sample (NIS).
METHODS METHODS
Data on HIV-related hospitalizations from 2005 to 2014 were obtained from the NIS database using International Classification of Diseases, 9th Revision (ICD-9) codes. Data was further subclassified into hospitalizations with associated arrhythmias and those without. Baseline demographics and comorbidities were determined. Outcomes including in-hospital mortality, cost of care, and length of stay were extracted. SAS 9.4 (SAS Institute Inc., Cary, NC) was utilized for analysis. A multivariable analysis was performed to identify predictors of arrhythmias among hospitalized HIV patients.
RESULTS RESULTS
Among 2 370 751 HIV-related hospitalizations identified, the overall frequency of any arrhythmia was 3.01%. Atrial fibrillation (AF) was the most frequent arrhythmia (2110 per 100 000). The overall frequency of arrhythmias increased over time by 108%, primarily due to a 132% increase in AF. Arrhythmias are more frequent among older males, lowest income quartile, and nonelective admissions. Patients with arrhythmias had a higher in-hospital mortality rate (9.6%). In-hospital mortality among patients with arrhythmias decreased over time by 43.8%. The cost of care and length of stay associated with arrhythmia-related hospitalizations were mostly unchanged.
CONCLUSIONS CONCLUSIONS
Arrhythmias are associated with significant morbidity and mortality in hospitalized HIV patients. AF is the most frequent arrhythmia in hospitalized HIV patients.

Identifiants

pubmed: 33295667
doi: 10.1002/clc.23506
pmc: PMC7803370
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-77

Informations de copyright

© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Références

Curr Atheroscler Rep. 2018 May 18;20(6):30
pubmed: 29777448
N Engl J Med. 2007 Apr 26;356(17):1723-35
pubmed: 17460226
J Natl Med Assoc. 2005 Dec;97(12):1657-61
pubmed: 16396057
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8
pubmed: 18645512
Clin Infect Dis. 2008 Aug 15;47(4):542-53
pubmed: 18627268
J Am Coll Cardiol. 2012 May 22;59(21):1891-6
pubmed: 22595409
Pacing Clin Electrophysiol. 1997 Nov;20(11):2810-6
pubmed: 9392812
Clin Cardiol. 2021 Jan;44(1):66-77
pubmed: 33295667
AIDS. 2009 Sep 10;23(14):1841-9
pubmed: 19455012
Am J Cardiol. 2015 Oct 15;116(8):1229-36
pubmed: 26297512
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):351-8
pubmed: 22580566
AIDS. 2002 Aug 16;16(12):1663-71
pubmed: 12172088
Annu Rev Med. 2011;62:141-55
pubmed: 21090961
Eff Clin Pract. 2002 May-Jun;5(3):143-51
pubmed: 12088294
J Am Coll Cardiol. 2013 Jun 4;61(22):2288-95
pubmed: 23563125
Lancet. 2005 Feb 19-25;365(9460):682-6
pubmed: 15721475
J Am Coll Cardiol. 1994 Oct;24(4):1018-24
pubmed: 7930192
Nat Rev Cardiol. 2015 Apr;12(4):230-43
pubmed: 25622848
Curr Cardiol Rev. 2009 May;5(2):149-54
pubmed: 20436855
AIDS. 2004 Nov 19;18(17):2333-7
pubmed: 15577550
Diabetes Care. 2007 Jan;30(1):113-9
pubmed: 17192343
AIDS. 2013 Sep 10;27(14):2301-5
pubmed: 23669155
Circulation. 2001 Dec 11;104(24):2886-91
pubmed: 11739301
Circulation. 2014 Jun 10;129(23):2371-9
pubmed: 24842943
Circulation. 2003 Dec 16;108(24):3006-10
pubmed: 14623805
Clin Infect Dis. 2003 Jul 15;37(2):292-8
pubmed: 12856222
J Cardiovasc Electrophysiol. 2002 Sep;13(9):936-8
pubmed: 12380935

Auteurs

Anas A Abudan (AA)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.
Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas, United States.

Vaibhav R Vaidya (VR)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Byomesh Tripathi (B)

Department of Medicine, Mount Sinai St Luke's-Roosevelt Hospital, New York, New York, United States.

Peter A Noseworthy (PA)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Daniel C DeSimone (DC)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.

Alexander Egbe (A)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Shilpkumar Arora (S)

Department of Medicine, Mount Sinai St Luke's-Roosevelt Hospital, New York, New York, United States.

Haarini Sridhar (H)

University of California, Berkeley, California, United States.

Christopher V DeSimone (CV)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Siva Mulpuru (S)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Abhishek J Deshmukh (AJ)

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH